A recent clinical study (Yang et al
NOT Appropriate for Acute Injuries Requiring Medical Intervention: Fractures, severe sprains, traumatic injuries, and conditions requiring immediate medical attention should be evaluated and treated by healthcare professionals
Semaglutide (Wegovy): Coverage is increasing, but policies vary
General switching guidelines: Notice that even people on the maximum semaglutide dose (2.4 mg) typically start tirzepatide at 5 mg, not at a higher dose
The third compared GLP-1 receptor agonist users with patients receiving SGLT2 inhibitors among those with type 2 diabetes
NICE guidance recommends reviewing diabetes treatment every 36 months, assessing glycaemic control, weight, tolerability, and any complications